Literature DB >> 28476857

Apolipoprotein A-II alters the proteome of human lipoproteins and enhances cholesterol efflux from ABCA1.

John T Melchior1, Scott E Street1, Allison B Andraski2, Jeremy D Furtado2, Frank M Sacks3, Rebecca L Shute1, Emily I Greve1, Debi K Swertfeger4, Hailong Li4, Amy S Shah5, L Jason Lu4, W Sean Davidson6.   

Abstract

HDLs are a family of heterogeneous particles that vary in size, composition, and function. The structure of most HDLs is maintained by two scaffold proteins, apoA-I and apoA-II, but up to 95 other "accessory" proteins have been found associated with the particles. Recent evidence suggests that these accessory proteins are distributed across various subspecies and drive specific biological functions. Unfortunately, our understanding of the molecular composition of such subspecies is limited. To begin to address this issue, we separated human plasma and HDL isolated by ultracentrifugation (UC-HDL) into particles with apoA-I and no apoA-II (LpA-I) and those with both apoA-I and apoA-II (LpA-I/A-II). MS studies revealed distinct differences between the subfractions. LpA-I exhibited significantly more protein diversity than LpA-I/A-II when isolated directly from plasma. However, this difference was lost in UC-HDL. Most LpA-I/A-II accessory proteins were associated with lipid transport pathways, whereas those in LpA-I were associated with inflammatory response, hemostasis, immune response, metal ion binding, and protease inhibition. We found that the presence of apoA-II enhanced ABCA1-mediated efflux compared with LpA-I particles. This effect was independent of the accessory protein signature suggesting that apoA-II induces a structural change in apoA-I in HDLs.
Copyright © 2017 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  ATP binding cassette transporter A1; high density lipoprotein/structure; proteomics

Mesh:

Substances:

Year:  2017        PMID: 28476857      PMCID: PMC5496035          DOI: 10.1194/jlr.M075382

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  63 in total

1.  A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples.

Authors:  M A Markwell; S M Haas; L L Bieber; N E Tolbert
Journal:  Anal Biochem       Date:  1978-06-15       Impact factor: 3.365

2.  The C-terminal domain of apolipoprotein A-I is involved in ABCA1-driven phospholipid and cholesterol efflux.

Authors:  Elda Favari; Franco Bernini; Patrizia Tarugi; Guido Franceschini; Laura Calabresi
Journal:  Biochem Biophys Res Commun       Date:  2002-12-20       Impact factor: 3.575

3.  Characterization of human high-density lipoproteins by gradient gel electrophoresis.

Authors:  P J Blanche; E L Gong; T M Forte; A V Nichols
Journal:  Biochim Biophys Acta       Date:  1981-09-24

4.  Multiple apolipoprotein kinetics measured in human HDL by high-resolution/accurate mass parallel reaction monitoring.

Authors:  Sasha A Singh; Allison B Andraski; Brett Pieper; Wilson Goh; Carlos O Mendivil; Frank M Sacks; Masanori Aikawa
Journal:  J Lipid Res       Date:  2016-02-09       Impact factor: 5.922

5.  ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages.

Authors:  J F Oram; R M Lawn; M R Garvin; D P Wade
Journal:  J Biol Chem       Date:  2000-11-03       Impact factor: 5.157

6.  The effect of apolipoprotein A-II on the structure and function of apolipoprotein A-I in a homogeneous reconstituted high density lipoprotein particle.

Authors:  D M Durbin; A Jonas
Journal:  J Biol Chem       Date:  1997-12-12       Impact factor: 5.157

7.  Proteomic characterization of human plasma high density lipoprotein fractionated by gel filtration chromatography.

Authors:  Scott M Gordon; Jingyuan Deng; L Jason Lu; W Sean Davidson
Journal:  J Proteome Res       Date:  2010-10-01       Impact factor: 4.466

8.  Structural and functional differences of subspecies of apoA-I-containing lipoprotein in patients with plasma cholesteryl ester transfer protein deficiency.

Authors:  T Ohta; R Nakamura; K Takata; Y Saito; S Yamashita; S Horiuchi; I Matsuda
Journal:  J Lipid Res       Date:  1995-04       Impact factor: 5.922

9.  The role of apolipoprotein A-I helix 10 in apolipoprotein-mediated cholesterol efflux via the ATP-binding cassette transporter ABCA1.

Authors:  Stacey E Panagotopulos; Scott R Witting; Erica M Horace; David Y Hui; J Nicholas Maiorano; W Sean Davidson
Journal:  J Biol Chem       Date:  2002-08-13       Impact factor: 5.157

10.  Apolipoprotein C-III as a Potential Modulator of the Association Between HDL-Cholesterol and Incident Coronary Heart Disease.

Authors:  Majken K Jensen; Eric B Rimm; Jeremy D Furtado; Frank M Sacks
Journal:  J Am Heart Assoc       Date:  2012-04-24       Impact factor: 5.501

View more
  23 in total

1.  Distinct Proteomic Signatures in 16 HDL (High-Density Lipoprotein) Subspecies.

Authors:  Jeremy D Furtado; Rain Yamamoto; John T Melchior; Allison B Andraski; Maria Gamez-Guerrero; Patrick Mulcahy; Zeling He; Tianxi Cai; W Sean Davidson; Frank M Sacks
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-12       Impact factor: 8.311

2.  Protein-Defined Subspecies of HDLs (High-Density Lipoproteins) and Differential Risk of Coronary Heart Disease in 4 Prospective Studies.

Authors:  Frank M Sacks; Liang Liang; Jeremy D Furtado; Tianxi Cai; W Sean Davidson; Zeling He; Robyn L McClelland; Eric B Rimm; Majken K Jensen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-09-10       Impact factor: 8.311

3.  Determinants of high-density lipoprotein (HDL) functions beyond proteome in Asian Indians: exploring the fatty acid profile of HDL phospholipids.

Authors:  Himani Thakkar; Vinnyfred Vincent; Ambuj Roy; Ajay Kumar Gautam; Rintu Kutum; Lakshmy Ramakrishnan; Sandeep Singh; Archna Singh
Journal:  Mol Cell Biochem       Date:  2021-11-29       Impact factor: 3.396

Review 4.  The HDL Proteome Watch: Compilation of studies leads to new insights on HDL function.

Authors:  W Sean Davidson; Amy S Shah; Hannah Sexmith; Scott M Gordon
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2021-11-18       Impact factor: 4.698

Review 5.  Deepening our understanding of HDL proteome.

Authors:  Graziella Eliza Ronsein; Tomáš Vaisar
Journal:  Expert Rev Proteomics       Date:  2019-08-27       Impact factor: 3.940

Review 6.  The Difference Between High Density Lipoprotein Subfractions and Subspecies: an Evolving Model in Cardiovascular Disease and Diabetes.

Authors:  W Sean Davidson; Allison L Cooke; Debi K Swertfeger; Amy S Shah
Journal:  Curr Atheroscler Rep       Date:  2021-03-27       Impact factor: 5.113

7.  MicroRNA-144 Silencing Protects Against Atherosclerosis in Male, but Not Female Mice.

Authors:  Joan Cheng; Angela Cheng; Bethan L Clifford; Xiaohui Wu; Ulf Hedin; Lars Maegdefessel; Nathalie Pamir; Tamer Sallam; Elizabeth J Tarling; Thomas Q de Aguiar Vallim
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-12-19       Impact factor: 10.514

8.  Associations between High-Density Lipoprotein Functionality and Major Adverse Cardiovascular Events in Patients Who Have Undergone Coronary Computed Tomography Angiography.

Authors:  Hiroko Inoue; Yuhei Shiga; Kenji Norimatsu; Kohei Tashiro; Makito Futami; Yasunori Suematsu; Makoto Sugihara; Hiroaki Nishikawa; Yousuke Katsuda; Shin-Ichiro Miura
Journal:  J Clin Med       Date:  2021-05-30       Impact factor: 4.241

9.  Studies in genetically modified mice implicate maternal HDL as a mediator of fetal growth.

Authors:  Sandra L Rebholz; John T Melchior; W Sean Davidson; Helen N Jones; Jeffrey A Welge; Andrew M Prentice; Sophie E Moore; Laura A Woollett
Journal:  FASEB J       Date:  2018-01-04       Impact factor: 5.834

10.  Modified sites and functional consequences of 4-oxo-2-nonenal adducts in HDL that are elevated in familial hypercholesterolemia.

Authors:  Linda S May-Zhang; Valery Yermalitsky; John T Melchior; Jamie Morris; Keri A Tallman; Mark S Borja; Tiffany Pleasent; Venkataraman Amarnath; Wenliang Song; Patricia G Yancey; W Sean Davidson; MacRae F Linton; Sean S Davies
Journal:  J Biol Chem       Date:  2019-10-30       Impact factor: 5.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.